IP Verse

Camulon patent opposition analysis

CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Latest oppositions filed by Camulon

Explore patent oppositions filed by Camulon against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Aug 28, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP4321157
New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)NOVARTISJul 21, 2025
EP3570885
Method Of Treating Or Ameliorating Metabolic Disorders Using Glp-1 Receptor Agonists Conjugated To Antagonists For Gastric Inhibitory Peptide Receptor (Gipr)AMGENJun 17, 2025
EP3697917
Vector For The Production Of Aav ParticlesOXFORD GENETICSFeb 14, 2025
EP3953262
Thin Wall Container Made With A Recycled MaterialSOCIT ANONYME DES EAUX MINRALES DEVIAN ET EN ABRG SAEMEDec 6, 2024
EP2395968
Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIMOct 14, 2024
EP3626270
New UseNOVARTISJul 10, 2024
EP3042669
Antitumor Agent And Antitumor Effect EnhancerTAIHO PHARMACEUTICALNov 29, 2023
EP3294283
Sacubitril-Valsartan Dosage Regimen For Treating Heart FailureNOVARTISNov 23, 2023
EP3883606
Safe And Effective Method Of Treating Ulcerative Colitis With Anti-Il12/Il23 AntibodyJANSSEN BIOTECHJul 27, 2023
EP3003360
High Potency Pancreatin Pharmaceutical CompositionsALLERGAN PHARMACEUTICALSJul 6, 2021

Top competitors of Camulon

Top competitors of Camulon based on patent oppositions.